Literature DB >> 22934927

PGE2 maintains the tone of the guinea pig trachea through a balance between activation of contractile EP1 receptors and relaxant EP2 receptors.

J Säfholm1, S-E Dahlén, I Delin, K Maxey, K Stark, L-O Cardell, M Adner.   

Abstract

BACKGROUND AND
PURPOSE: The guinea pig trachea (GPT) is commonly used in airway pharmacology. The aim of this study was to define the expression and function of EP receptors for PGE(2) in GPT as there has been ambiguity concerning their role. EXPERIMENTAL APPROACH: Expression of mRNA for EP receptors and key enzymes in the PGE(2) pathway were assessed by real-time PCR using species-specific primers. Functional studies of GPT were performed in tissue organ baths. KEY
RESULTS: Expression of mRNA for the four EP receptors was found in airway smooth muscle. PGE(2) displayed a bell-shaped concentration-response curve, where the initial contraction was inhibited by the EP(1) receptor antagonist ONO-8130 and the subsequent relaxation by the EP(2) receptor antagonist PF-04418948. Neither EP(3) (ONO-AE5-599) nor EP(4) (ONO-AE3-208) selective receptor antagonists affected the response to PGE(2). Expression of COX-2 was greater than COX-1 in GPT, and the spontaneous tone was most effectively abolished by selective COX-2 inhibitors. Furthermore, ONO-8130 and a specific PGE(2) antibody eliminated the spontaneous tone, whereas the EP(2) antagonist PF-04418948 increased it. Antagonists of other prostanoid receptors had no effect on basal tension. The relaxant EP(2) response to PGE(2) was maintained after long-term culture, whereas the contractile EP(1) response showed homologous desensitization to PGE(2), which was prevented by COX-inhibitors. CONCLUSIONS AND IMPLICATIONS: Endogenous PGE(2), synthesized predominantly by COX-2, maintains the spontaneous tone of GPT by a balance between contractile EP(1) receptors and relaxant EP(2) receptors. The model may be used to study interactions between EP receptors.
© 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22934927      PMCID: PMC3631371          DOI: 10.1111/j.1476-5381.2012.02189.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  59 in total

1.  The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs.

Authors:  M Abramovitz; M Adam; Y Boie; M Carrière; D Denis; C Godbout; S Lamontagne; C Rochette; N Sawyer; N M Tremblay; M Belley; M Gallant; C Dufresne; Y Gareau; R Ruel; H Juteau; M Labelle; N Ouimet; K M Metters
Journal:  Biochim Biophys Acta       Date:  2000-01-17

2.  Guidelines for reporting experiments involving animals: the ARRIVE guidelines.

Authors:  J C McGrath; G B Drummond; E M McLachlan; C Kilkenny; C L Wainwright
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  Cyclooxygenase-2 expression during allergic inflammation in guinea-pig lungs.

Authors:  Tsuyoshi Oguma; Koichiro Asano; Tetsuya Shiomi; Kouichi Fukunaga; Yusuke Suzuki; Morio Nakamura; Hiroaki Matsubara; Holly K Sheldon; Kathleen J Haley; Craig M Lilly; Jeffrey M Drazen; Kazuhiro Yamaguchi
Journal:  Am J Respir Crit Care Med       Date:  2002-02-01       Impact factor: 21.405

4.  Arrestin specificity for G protein-coupled receptors in human airway smooth muscle.

Authors:  R B Penn; R M Pascual; Y M Kim; S J Mundell; V P Krymskaya; R A Panettieri; J L Benovic
Journal:  J Biol Chem       Date:  2001-06-20       Impact factor: 5.157

5.  PGE(2) receptor (EP(4)) agonists: potent dilators of human bronchi and future asthma therapy?

Authors:  C Benyahia; I Gomez; L Kanyinda; K Boukais; C Danel; G Leséche; D Longrois; X Norel
Journal:  Pulm Pharmacol Ther       Date:  2012-01-06       Impact factor: 3.410

6.  Prostaglandin E(2) increases cyclic AMP and inhibits endothelin-1 production/secretion by guinea-pig tracheal epithelial cells through EP(4) receptors.

Authors:  S Pelletier; J Dubé; A Villeneuve; F Gobeil; Q Yang; B Battistini; G Guillemette; P Sirois
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

7.  The analgesic effect profile of FR122047, a selective cyclooxygenase-1 inhibitor, in chemical nociceptive models.

Authors:  T Ochi; Y Motoyama; T Goto
Journal:  Eur J Pharmacol       Date:  2000-03-10       Impact factor: 4.432

8.  In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP₂ receptor antagonist.

Authors:  K J af Forselles; J Root; T Clarke; D Davey; K Aughton; K Dack; N Pullen
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

9.  Interaction of prostanoid EP₃ and TP receptors in guinea-pig isolated aorta: contractile self-synergism of 11-deoxy-16,16-dimethyl PGE₂.

Authors:  R L Jones; D F Woodward
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

10.  EP4 receptor as a new target for bronchodilator therapy.

Authors:  James Buckley; Mark A Birrell; Sarah A Maher; Anthony T Nials; Deborah L Clarke; Maria G Belvisi
Journal:  Thorax       Date:  2011-05-23       Impact factor: 9.139

View more
  9 in total

Review 1.  Emerging concepts in smooth muscle contributions to airway structure and function: implications for health and disease.

Authors:  Y S Prakash
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-10-14       Impact factor: 5.464

Review 2.  Transforming Growth Factor β1 Function in Airway Remodeling and Hyperresponsiveness. The Missing Link?

Authors:  Christie A Ojiaku; Edwin J Yoo; Reynold A Panettieri
Journal:  Am J Respir Cell Mol Biol       Date:  2017-04       Impact factor: 6.914

Review 3.  The role of prostaglandins in allergic lung inflammation and asthma.

Authors:  Dru Claar; Tina V Hartert; Ray Stokes Peebles
Journal:  Expert Rev Respir Med       Date:  2014-12-26       Impact factor: 3.772

4.  Ca2+-independent phospholipase A2β-derived PGE2 contributes to osteogenesis.

Authors:  William D Hancock; Xiaoyong Lei; Gregory A Clines; Ying G Tusing; Susan E Nozell; Sasanka Ramanadham
Journal:  Prostaglandins Other Lipid Mediat       Date:  2021-12-16       Impact factor: 3.072

5.  Ozone-induced injury and oxidative stress in bronchiolar epithelium are associated with altered pulmonary mechanics.

Authors:  Vasanthi R Sunil; Kinal N Vayas; Christopher B Massa; Andrew J Gow; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Sci       Date:  2013-03-14       Impact factor: 4.849

Review 6.  Prostaglandins in asthma and allergic diseases.

Authors:  R Stokes Peebles
Journal:  Pharmacol Ther       Date:  2018-08-03       Impact factor: 12.310

7.  Prostaglandin E2 breaks down pericyte-endothelial cell interaction via EP1 and EP4-dependent downregulation of pericyte N-cadherin, connexin-43, and R-Ras.

Authors:  Carole Y Perrot; Jose L Herrera; Ashley E Fournier-Goss; Masanobu Komatsu
Journal:  Sci Rep       Date:  2020-07-07       Impact factor: 4.379

8.  The cyclooxygenase-1/mPGES-1/endothelial prostaglandin EP4 receptor pathway constrains myocardial ischemia-reperfusion injury.

Authors:  Liyuan Zhu; Chuansheng Xu; Xingyu Huo; Huifeng Hao; Qing Wan; Hong Chen; Xu Zhang; Richard M Breyer; Yu Huang; Xuetao Cao; De-Pei Liu; Garret A FitzGerald; Miao Wang
Journal:  Nat Commun       Date:  2019-04-23       Impact factor: 14.919

9.  Thrombin Induces COX-2 and PGE2 Expression via PAR1/PKCalpha/MAPK-Dependent NF-kappaB Activation in Human Tracheal Smooth Muscle Cells.

Authors:  Chien-Chung Yang; Li-Der Hsiao; Ya-Fang Shih; Chih-Kai Hsu; Chia-Yu Hu; Chuen-Mao Yang
Journal:  Mediators Inflamm       Date:  2022-04-19       Impact factor: 4.529

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.